Abstract
Cartilage defects heal imperfectly and osteoarthritic changes develop frequently as a result. Although the existence of specific behaviours of chondrocytes derived from various depth-related zones in vitro has been known for over 20years, only a relatively small body of in vitro studies has been performed with zonal chondrocytes and current clinical treatment strategies do not reflect these native depth-dependent (zonal) differences. This is surprising since mimicking the zonal organization of articular cartilage in neo-tissue by the use of zonal chondrocyte subpopulations could enhance the functionality of the graft. Although some research groups including our own have made considerable progress in tailoring culture conditions using specific growth factors and biomechanical loading protocols, we conclude that an optimal regime has not yet been determined. Other unmet challenges include the lack of specific zonal cell sorting protocols and limited amounts of cells harvested per zone. As a result, the engineering of functional tissue has not yet been realized and no long-term in vivo studies using zonal chondrocytes have been described. This paper critically reviews the research performed to date and outlines our view of the potential future significance of zonal chondrocyte populations in regenerative approaches for the treatment of cartilage defects. Secondly, we briefly discuss the capabilities of additive manufacturing technologies that can not only create patient-specific grafts directly from medical imaging data sets but could also more accurately reproduce the complex 3D zonal extracellular matrix architecture using techniques such as hydrogel-based cell printing. Copyright (c) 2012 John Wiley & Sons, Ltd.
Original language | English |
---|---|
Pages (from-to) | 669-678 |
Number of pages | 10 |
Journal | Journal of Tissue Engineering and Regenerative Medicine |
Volume | 9 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2015 |
Keywords
- cartilage
- zonal
- regeneration
- bioprinting
- additive manufacturing
- chondrocytes
- HUMAN ARTICULAR CHONDROCYTES
- OLIGOMERIC MATRIX PROTEIN
- TISSUE-ENGINEERED CARTILAGE
- MESENCHYMAL STEM-CELLS
- IN-VITRO
- SUPERFICIAL ZONE
- EXTRACELLULAR-MATRIX
- PROGENITOR CELLS
- SURFACE MOTION
- GROWTH-FACTORS